Table of Contents

company-logo

Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. It develops hyFc platform, a proprietary technology designed to drive the discovery of various differentiated agonistic protein therapeutics; and the Immune Enhancing Technology, a therapeutic DNA vaccine technology. The company's product pipeline includes GX-H9, which is in Phase II clinical trials for the treatment of adult and pediatric growth hormone deficiency; GX-E2, which is in Phase II clinical trials for the treatment of induced anemia; GX-G3, which is in Phase II clinical trials to treat neutropenia; and GX-G6 that is in Phase I clinical trials for the treatment of diabetes. It is also developing GX-188E that is in Phase II clinical trials in combination with KEYTRUDA for the treatment of cervical cancer. Genexine, Inc. has a co-development partnership with Binex Co. Ltd. to develop COVID-19 vaccine. The company was formerly known as Genexine Co., Ltd. and changed its name to Genexine, Inc. in March 2013. Genexine, Inc. was founded in 1999 and is based in Seongnam, South Korea.

Genexine Dividend Announcement

• Genexine announced a annually dividend of ₩0.28 per ordinary share which will be made payable on . Ex dividend date: 2022-03-15
• Genexine's trailing twelve-month (TTM) dividend yield is -%

Genexine Dividend History

Ex-Div dateDividend amountDividend typePay date
2022-03-15₩0.28annually

Genexine Dividend per year

Genexine Dividend Yield

Genexine current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Genexine stock? Use our calculator to estimate your expected dividend yield:

Genexine Financial Ratios

P/E ratio-6.53
PEG ratio0.07
P/B ratio1.00
ROE-14.57%
Payout ratio0.00%
Current ratio1.23
Quick ratio1.17
Cash Ratio0.04

Genexine Dividend FAQ

Does Genexine stock pay dividends?
Genexine does not currently pay dividends to its shareholders.
Has Genexine ever paid a dividend?
No, Genexine has no a history of paying dividends to its shareholders. Genexine is not known for its dividend payments.
Why doesn't Genexine pay dividends?
There are several potential reasons why Genexine would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Genexine ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Genexine has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Genexine a dividend aristocrat?
Genexine is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Genexine a dividend king?
Genexine is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Genexine a dividend stock?
No, Genexine is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Genexine stocks?
To buy Genexine you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Genexine stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.